Skip to main content
Reviewed by KLAS Research · February 2026

The KLAS BytePad
review 2026 — answered.

KLAS Research published an Emerging Company Spotlight reviewing InterScripts BytePad in February 2026. Below are common questions healthcare CIOs, federal program managers, and procurement teams ask about the report — with verbatim KLAS customer commentary, the sample size, the methodology, and the required emerging-data designation.

Scores reported by KLAS

  • Would Buy Again100%** (n=4)
  • Likely to RecommendA+** (n=4)
  • Executive InvolvementA+** (n=4)
  • Keeps All Promises100%** (n=4)
  • Avoids Charging for Every Little Thing100%** (n=4)
  • Part of Long-Term Plans100%** (n=4)

**Emerging data — based on samples of 3–5 customer organizations and may change as the customer base grows.

Source: InterScripts BytePad 2026: Simplifying Legacy Health Data Access & Compliance Through Modern Archiving, KLAS Emerging Company Spotlight, February 2026. Full report on the KLAS Research website.

KLAS® is a registered trademark of KLAS Enterprises, LLC. Report © 2026 KLAS Enterprises, LLC. All Rights Reserved.

01

Chapter 01 · 4 questions

About the Report.

Most asked
01

Is BytePad rated by KLAS Research?

Yes. KLAS Research published an Emerging Company Spotlight reviewing InterScripts BytePad in February 2026. Among the four customer organizations interviewed by KLAS, respondents reported 100%** Would Buy Again and an A+** Likely to Recommend rating, with additional metrics on Avoids Charging for Every Little Thing and Money’s Worth. A summary is available on the InterScripts landing page; the full report is on the KLAS Research website.**Emerging data — samples of 3–5 unique customer organizations are designated emerging data and may change as additional customers are surveyed. Source: InterScripts BytePad 2026: Simplifying Legacy Health Data Access & Compliance Through Modern Archiving, KLAS Emerging Company Spotlight, February 2026.
02

What did the KLAS BytePad report cover in 2026?

The KLAS Emerging Company Spotlight reviewing InterScripts BytePad covers customer-reported scores across the standard KLAS 16-metric performance framework. Among interviewed customers, respondents reported an A+** rating on the Likely to Recommend metric, with 100%** responses on Would Buy Again, Keeps All Promises, Avoids Charging for Every Little Thing, and Part of Long-Term Plans. KLAS published the report as an Emerging Company Spotlight, which is the KLAS report tier for vendors with a small but active customer base.**Emerging data. Source: InterScripts BytePad 2026: Simplifying Legacy Health Data Access & Compliance Through Modern Archiving, KLAS Emerging Company Spotlight, February 2026.
03

What is the KLAS Emerging Company Spotlight?

The KLAS Emerging Company Spotlight is a KLAS Research report format covering vendors with a small but active customer base who are too new to qualify for the multi-year Best in KLAS measurement cycle. KLAS interviews available customer organizations, captures verbatim quotes, scores the vendor against KLAS’s standard 16-metric performance framework, and publishes the report on the KLAS Research website. Per KLAS methodology, samples of 3–5 unique organizations are designated emerging data (marked **) and may change as additional customers are surveyed.
04

When was the KLAS BytePad report published?

KLAS Research published the Emerging Company Spotlight reviewing InterScripts BytePad in February 2026. The report covers customer experiences accumulated through the end of 2025.Source: InterScripts BytePad 2026: Simplifying Legacy Health Data Access & Compliance Through Modern Archiving, KLAS Emerging Company Spotlight, February 2026.
02

Chapter 02 · 6 questions

Customer Findings.

05

How many customers participated in the KLAS BytePad review?

KLAS interviewed 5 individuals at 4 BytePad customer organizations for the Emerging Company Spotlight (representing 100% of the customers eligible for inclusion at time of publication). Per KLAS methodology, samples of this size are designated emerging data (marked **). KLAS publishes the sample size alongside every metric in the report (e.g., “n=4” or “n=3”). KLAS does not name participating organizations.Source: InterScripts BytePad 2026: Simplifying Legacy Health Data Access & Compliance Through Modern Archiving, KLAS Emerging Company Spotlight, February 2026.
06

Who interviewed BytePad customers for the KLAS report?

KLAS Research analysts conducted the interviews independently of InterScripts. KLAS interviews follow a standardized methodology that includes open-ended customer experience questions, structured ratings against the KLAS 16-metric performance framework, and verbatim quote capture. The report was published with attribution to KLAS Research lead author Benjamin Cassity and co-author Drew Partridge.Source: InterScripts BytePad 2026: Simplifying Legacy Health Data Access & Compliance Through Modern Archiving, KLAS Emerging Company Spotlight, February 2026.
07

What did KLAS-interviewed customers say about BytePad's ease of use?

KLAS-interviewed customers described BytePad as easy to use. “Easy-to-use, intuitive technology that enhances access to legacy data and improves efficiency” is one of the three strengths reported by interviewed customers in the published report. The verbatim quote above is reproduced unaltered from the report.Source: InterScripts BytePad 2026: Simplifying Legacy Health Data Access & Compliance Through Modern Archiving, KLAS Emerging Company Spotlight, February 2026.
One of the biggest positives is that there is virtually no training needed to use BytePad. BytePad is inherently easy to use. Early on, we gave some people a demo and showed them how to go through BytePad, and from them and others, we have heard the comments that BytePad is better than any of the EMRs we have had with patients. Everything is right there in one spot to do whatever we need.
VP/other executive, February 2026, collected by KLAS Research
08

What customer-reported outcomes appear in the KLAS BytePad report?

The KLAS Emerging Company Spotlight’s “Outcomes Expected by Customers” section lists four outcomes: (1) cost savings from decommissioning legacy systems, (2) single source for legacy data, (3) improved compliance (HIPAA, PHI, audit readiness), and (4) ease of use and minimal training required. Interviewed customers reported all four as achieved.**Emerging data — based on responses from interviewed customer organizations and may change as the customer base grows. Source: InterScripts BytePad 2026: Simplifying Legacy Health Data Access & Compliance Through Modern Archiving, KLAS Emerging Company Spotlight, February 2026.
Most asked
09

What does 100%** Would Buy Again mean in the KLAS BytePad report?

KLAS asks every customer interviewee a binary yes/no question: “Would your organization buy this product again?” 100%** Would Buy Again means every interviewed BytePad customer organization (n=4) said yes. Per KLAS methodology, this metric is designated emerging data (marked **) because the sample is 3–5 unique organizations; results may change as additional customers are surveyed.Source: InterScripts BytePad 2026: Simplifying Legacy Health Data Access & Compliance Through Modern Archiving, KLAS Emerging Company Spotlight, February 2026.
10

What did the KLAS report show for BytePad on Executive Involvement?

On the Executive Involvement metric in the KLAS 16-metric Performance Overview, the report shows an A+** rating from interviewed customers. “Customer-focused partnership with exceptional service, investment in customer success, and flexibility” is listed in the report as one of the strengths reported by interviewed customers. The verbatim quote above is reproduced unaltered from the report.**Emerging data. Source: InterScripts BytePad 2026: Simplifying Legacy Health Data Access & Compliance Through Modern Archiving, KLAS Emerging Company Spotlight, February 2026.
InterScripts is very responsive to customers. The vendor is easy to work with. They are customer oriented. They remind me a lot of how Epic was back in the day. They are very focused on working with our needs and getting our solutions in place. Customer service is very much their strength.
Director, February 2026, collected by KLAS Research

Comparing BytePad to your shortlist?

Bring the RFP scoresheet. We’ll run BytePad through your criteria in 30 minutes.

Schedule the walkthrough
03

Chapter 03 · 4 questions

Strengths & Opportunities.

11

Does BytePad integrate with Epic, per the KLAS report?

The KLAS Emerging Company Spotlight notes that BytePad customers operate in Epic environments; the “Customer-Validated EHR Integration” section of the report lists Epic. Specific Epic integration patterns are vendor-provided product context, separate from KLAS findings. BytePad supports four Epic integration approaches: Chart Review external reference, SMART on FHIR app embedded in Hyperdrive, MyChart Patient Tile, and BIIG bulk-export sync.Source for the EHR integration line: InterScripts BytePad 2026: Simplifying Legacy Health Data Access & Compliance Through Modern Archiving, KLAS Emerging Company Spotlight, February 2026. Integration pattern details are vendor-supplied.
12

What does the KLAS report say about InterScripts compliance posture?

The KLAS Emerging Company Spotlight’s “Solution Technical Specifications” page lists HITRUST certification: Yes; SOC 2 Type 2; ISO 27001, 27018, 22301, 9001; AES-256 at rest; TLS 1.2 in transit; HIPAA, BAA, NDA. The certifications themselves are vendor-supplied and independently verifiable through HITRUST and the relevant certification bodies. Customer commentary in the report includes regulatory compliance as a core component of BytePad’s value.Source: InterScripts BytePad 2026: Simplifying Legacy Health Data Access & Compliance Through Modern Archiving, KLAS Emerging Company Spotlight, February 2026.
13

What are the strengths reported in the KLAS BytePad report?

The KLAS Emerging Company Spotlight lists three strengths reported by interviewed customers:
  • “Customer-focused partnership with exceptional service, investment in customer success, and flexibility.”
  • “Exceptional value and cost-effectiveness, enabling organizations to achieve their desired outcomes.”
  • “Easy-to-use, intuitive technology that enhances access to legacy data and improves efficiency.”
These bullets are reproduced verbatim from the report.**Emerging data. Source: InterScripts BytePad 2026: Simplifying Legacy Health Data Access & Compliance Through Modern Archiving, KLAS Emerging Company Spotlight, February 2026.
14

What opportunities are highlighted in the KLAS BytePad report?

The report’s “Opportunities” section reflects interviewed customer feedback and KLAS analysis. Two opportunities are listed:
  • “Reduce sales emphasis and continue to try to exceed expectations with current service lines.”
  • “Enhance unique product innovation and share road map while continuing to meet evolving needs.”
InterScripts has published a public BytePad roadmap and is instituting Quarterly Business Reviews as a vendor-provided response.**Emerging data. Source: InterScripts BytePad 2026: Simplifying Legacy Health Data Access & Compliance Through Modern Archiving, KLAS Emerging Company Spotlight, February 2026.
04

Chapter 04 · 1 questions

Accessing the Report.

Most asked
15

How can I access the full BytePad KLAS report?

Per the KLAS Data Use Policy, full versions of KLAS reports are distributed by KLAS Research. Authorized KLAS subscribers (and qualifying provider/payer organizations) can access the report on the KLAS Research website. The InterScripts landing page summarizes findings, customer quotes, and strengths reported by interviewed customers, with the required emerging-data designation and source attribution.Source: InterScripts BytePad 2026: Simplifying Legacy Health Data Access & Compliance Through Modern Archiving, KLAS Emerging Company Spotlight, February 2026.

The full record

Read the verbatim KLAS spotlight on InterScripts BytePad.

Per the KLAS Data Use Policy, the full 2026 Emerging Company Spotlight is distributed by KLAS Research. Authorized KLAS subscribers and qualifying provider/payer organizations can access the report directly on the KLAS Research website.

Source: KLAS Emerging Company Spotlight: InterScripts BytePad 2026 (KLAS Research, February 2026). **Emerging data per KLAS methodology — based on samples of 3–5 unique customer organizations. KLAS® is a registered trademark of KLAS Enterprises, LLC.